Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
出版年份 2017 全文链接
标题
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
作者
关键词
-
出版物
Science Translational Medicine
Volume 9, Issue 410, Pages eaan5616
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2017-10-05
DOI
10.1126/scitranslmed.aan5616
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival
- (2017) Taejong Song et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- TGF-B1 inhibition with losartan in combination with FOLFIRINOX (F-NOX) in locally advanced pancreatic cancer (LAPC): Preliminary feasibility and R0 resection rates from a prospective phase II study.
- (2017) Janet E. Murphy et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of angiotensin system inhibitors on survival in newly diagnosed glioma patients and recurrent glioblastoma patients receiving chemotherapy and/or bevacizumab
- (2017) Victor A. Levin et al. JOURNAL OF NEURO-ONCOLOGY
- Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
- (2017) Matthias Pinter et al. United European Gastroenterology Journal
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) B. Escudier et al. ANNALS OF ONCOLOGY
- Prognostic Impact of Renin-Angiotensin Inhibitors in Patients with Bladder Cancer Undergoing Radical Cystectomy
- (2016) Takashi Yoshida et al. ANNALS OF SURGICAL ONCOLOGY
- No Survival Benefit from the Inhibition of Renin–Angiotensin System in Biliary Tract Cancer
- (2016) YOUSUKE NAKAI et al. ANTICANCER RESEARCH
- Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers
- (2016) Zachary S. Morris et al. CANCER
- Abstract 3975: Matrix-depleting anti-hypertensives decompress tumor blood vessels and improve perfusion in patients with glioblastomas receiving anti-angiogenic therapy
- (2016) Kyrre E. Emblem et al. CANCER RESEARCH
- Angiotensin II Enhances Proliferation and Inflammation through AT1/PKC/NF-κB Signaling Pathway in Hepatocellular Carcinoma Cells
- (2016) Yuanyuan Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs)
- (2016) Abduelmenem Alashkham et al. Clinical Genitourinary Cancer
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy
- (2016) Lars Hofmann et al. EUROPEAN JOURNAL OF CANCER
- Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials
- (2016) Michael J. Sorich et al. INTERNATIONAL JOURNAL OF CANCER
- Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis
- (2016) Sara Raimondi et al. INTERNATIONAL JOURNAL OF CANCER
- Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system
- (2016) Linh Nguyen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Impact of Angiotensin-II receptor blockers on vasogenic edema in glioblastoma patients
- (2016) Antoine Kourilsky et al. JOURNAL OF NEUROLOGY
- Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
- (2016) Naomi B Haas et al. LANCET
- Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer
- (2016) Ketan Patel et al. Nanomedicine
- Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
- (2016) Hong Jiang et al. NATURE MEDICINE
- The Association between Angiotensin Receptor Blocker Usage and Breast Cancer Characteristics
- (2016) Hadar Goldvaser et al. ONCOLOGY
- Angiotensin (1-7) and Alamandine: Similarities and differences
- (2016) Tawar Qaradakhi et al. PHARMACOLOGICAL RESEARCH
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- Impact of Angiotensin I-converting Enzyme Inhibitors and Angiotensin II Type-1 Receptor Blockers on Survival of Patients with NSCLC
- (2016) Lili Miao et al. Scientific Reports
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma
- (2015) Eric A. Mellon et al. ACTA ONCOLOGICA
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma
- (2015) H. Izzedine et al. ANNALS OF ONCOLOGY
- Prognostic Impact of Renin–Angiotensin System Blockade on Renal Cell Carcinoma After Surgery
- (2015) Akira Miyajima et al. ANNALS OF SURGICAL ONCOLOGY
- Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway
- (2015) Shuai Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma
- (2015) Li-Ru He et al. BMC CANCER
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
- (2015) R. R. McKay et al. CLINICAL CANCER RESEARCH
- Incidental Receipt of Cardiac Medications and Survival Outcomes Among Patients With Stage III Non–Small-Cell Lung Cancer After Definitive Radiotherapy
- (2015) Hongmei Wang et al. Clinical Lung Cancer
- Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma
- (2015) E. Januel et al. EUROPEAN JOURNAL OF NEUROLOGY
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
- (2015) Stefano Ugel et al. JOURNAL OF CLINICAL INVESTIGATION
- Metastatic Colorectal Cancer: Current State and Future Directions
- (2015) Marwan G. Fakih JOURNAL OF CLINICAL ONCOLOGY
- VEGF-A modulates expression of inhibitory checkpoints on CD8+T cells in tumors
- (2015) Thibault Voron et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients
- (2015) Antonio Facciorusso et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer
- (2015) Michael L. Blute et al. JOURNAL OF UROLOGY
- Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib
- (2015) Adnan Aydiner et al. MEDICINE
- Combination cancer immunotherapies tailored to the tumour microenvironment
- (2015) Mark J. Smyth et al. Nature Reviews Clinical Oncology
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Association between AT1 and AT2 angiotensin II receptor expression with cell proliferation and angiogenesis in operable breast cancer
- (2015) Oscar Arrieta et al. TUMOR BIOLOGY
- G-protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
- (2015) Sylvie Rodrigues-Ferreira et al. Frontiers in Pharmacology
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- Drugs affecting the renin-angiotensin system and survival from cancer: a population based study of breast, colorectal and prostate cancer patient cohorts
- (2014) Chris R Cardwell et al. BMC Medicine
- Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
- (2014) Denise M. Boudreau et al. BREAST CANCER RESEARCH AND TREATMENT
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- The Angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer
- (2014) Mitsuyoshi Okazaki et al. CANCER LETTERS
- The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients
- (2014) Yousuke Nakai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice
- (2014) Annie Mirsoian et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma
- (2014) Yen-Hao Chen et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells
- (2014) Xiao Z Shen et al. LABORATORY INVESTIGATION
- The effect of calcium channel blockers on the outcome of acute myeloid leukemia
- (2014) Young Kwang Chae et al. LEUKEMIA & LYMPHOMA
- Olmesartan Potentiates the Anti-Angiogenic Effect of Sorafenib in Mice Bearing Ehrlich's Ascites Carcinoma: Role of Angiotensin (1–7)
- (2014) Mohammad M. Abd-Alhaseeb et al. PLoS One
- Reactive Oxygen Species Prevent Imiquimod-Induced Psoriatic Dermatitis through Enhancing Regulatory T Cell Function
- (2014) Hyung-Ran Kim et al. PLoS One
- Transcriptional Network Analysis Reveals that AT1 and AT2 Angiotensin II Receptors Are Both Involved in the Regulation of Genes Essential for Glioma Progression
- (2014) Hátylas Azevedo et al. PLoS One
- An FDA overview of rodent carcinogenicity studies of angiotensin II AT-1 receptor blockers: Pulmonary adenomas and carcinomas
- (2014) William T. Link et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer
- (2014) Diana R. Engineer et al. Translational Oncology
- The desmoplastic stroma of pancreatic cancer is a barrier to immune cell infiltration
- (2014) Jennifer Watt et al. OncoImmunology
- Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis
- (2013) Derick Okwan-Duodu et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Clinical biomarkers of response in advanced renal cell carcinoma
- (2013) A. Ravaud et al. ANNALS OF ONCOLOGY
- Oxidative Stress in Malignant Melanoma Enhances Tumor Necrosis Factor-α Secretion of Tumor-Associated Macrophages That Promote Cancer Cell Invasion
- (2013) Xuzhu Lin et al. ANTIOXIDANTS & REDOX SIGNALING
- Beta blockers and angiotensin-converting enzyme inhibitors’ purported benefit on breast cancer survival may be explained by aspirin use
- (2013) Michelle D. Holmes et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women
- (2013) Edoardo Botteri et al. BREAST CANCER RESEARCH AND TREATMENT
- Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
- (2013) Signy Holmes et al. Cancer Epidemiology
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Angiotensin II Induces Angiogenic Factors Production Partly Via AT1/JAK2/STAT3/SOCS3 Signaling Pathway in MHCC97H Cells
- (2013) Yuanyuan Ji et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Angiotensin II Drives the Production of Tumor-Promoting Macrophages
- (2013) Virna Cortez-Retamozo et al. IMMUNITY
- Mitochondria Are Required for Antigen-Specific T Cell Activation through Reactive Oxygen Species Signaling
- (2013) Laura A. Sena et al. IMMUNITY
- A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2
- (2013) Yousuke Nakai et al. INVESTIGATIONAL NEW DRUGS
- 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
- (2013) Paul A. James et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study
- (2013) Gitte Vrelits Sørensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
- (2013) Rakesh K. Jain JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
- (2013) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models
- (2013) Chandraiah Godugu et al. JOURNAL OF CONTROLLED RELEASE
- Aging predisposes to acute inflammatory induced pathology after tumor immunotherapy
- (2013) Myriam N. Bouchlaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward
- (2013) Adeera Levin et al. KIDNEY INTERNATIONAL
- Effect of β-Blockers and Other Antihypertensive Drugs On the Risk of Melanoma Recurrence and Death
- (2013) Vincenzo De Giorgi et al. MAYO CLINIC PROCEEDINGS
- Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy
- (2013) Kyrre E Emblem et al. NATURE MEDICINE
- Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2013) D. Keizman et al. ONCOLOGIST
- FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience
- (2013) J. E. Faris et al. ONCOLOGIST
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice
- (2013) Atsushi Masamune et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Use of ACE Inhibitors and Angiotensin Receptor Blockers and Primary Breast Cancer Outcomes
- (2013) Young Kwang Chae et al. Journal of Cancer
- Regulation of Monocyte Chemoattractant Protein-1 Through Angiotensin II Type 1 Receptor in Prostate Cancer
- (2012) Suguru Shirotake et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic Value of Renin–Angiotensin System Blockade in Non-muscle-invasive Bladder Cancer
- (2012) Kazuyuki Yuge et al. ANNALS OF SURGICAL ONCOLOGY
- Efficacy of angiotensin-receptor blockers on demographic and clinico-pathological characteristics of breast cancer
- (2012) Mehmet A.N. Şendur et al. BREAST
- Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1
- (2012) Yousuke Nakai et al. CANCER SCIENCE
- 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
- (2012) et al. CIRCULATION
- Rapid Angiogenesis Onset after Discontinuation of Sunitinib Treatment of Renal Cell Carcinoma Patients
- (2012) A. W. Griffioen et al. CLINICAL CANCER RESEARCH
- Steroid-sparing effects of angiotensin-II inhibitors in glioblastoma patients
- (2012) A. F. Carpentier et al. EUROPEAN JOURNAL OF NEUROLOGY
- How Does Inhibition of the Renin-Angiotensin System Affect the Prognosis of Advanced Gastric Cancer Patients Receiving Platinum-Based Chemotherapy?
- (2012) Seung Tae Kim et al. ONCOLOGY
- Clinical Outcomes of Chemotherapy for Diabetic and Nondiabetic Patients With Pancreatic Cancer
- (2012) Yousuke Nakai et al. PANCREAS
- Losartan Slows Pancreatic Tumor Progression and Extends Survival of SPARC-Null Mice by Abrogating Aberrant TGFβ Activation
- (2012) Shanna A. Arnold et al. PLoS One
- Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
- (2012) Y. Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Controversies on the role of Th17 in cancer: a TGF-β-dependent immunosuppressive activity?
- (2012) François Martin et al. TRENDS IN MOLECULAR MEDICINE
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort
- (2011) Patricia A. Ganz et al. BREAST CANCER RESEARCH AND TREATMENT
- Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
- (2011) N Tanaka et al. BRITISH JOURNAL OF CANCER
- Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer
- (2011) N Tanaka et al. BRITISH JOURNAL OF CANCER
- Reduced Risk of Breast Cancer Recurrence in Patients Using ACE Inhibitors, ARBs, and/or Statins
- (2011) Young Kwang Chae et al. CANCER INVESTIGATION
- Increased Survival of Glioblastoma Patients Who Respond to Antiangiogenic Therapy with Elevated Blood Perfusion
- (2011) A. G. Sorensen et al. CANCER RESEARCH
- The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis
- (2011) Xiao Z. Shen et al. CELL CYCLE
- Molecular Pathways: Hypoxia Response in Immune Cells Fighting or Promoting Cancer
- (2011) Asis Palazón et al. CLINICAL CANCER RESEARCH
- Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination
- (2011) Daniel Keizman et al. EUROPEAN JOURNAL OF CANCER
- The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
- (2011) Thomas Powles et al. EUROPEAN UROLOGY
- Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
- (2011) Amal Melhem-Bertrandt et al. JOURNAL OF CLINICAL ONCOLOGY
- The carboxypeptidase ACE shapes the MHC class I peptide repertoire
- (2011) Xiao Z Shen et al. NATURE IMMUNOLOGY
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
- (2011) B. Diop-Frimpong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer
- (2011) Suguru Shirotake et al. UROLOGY
- Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
- (2010) Michael Bader Annual Review of Pharmacology and Toxicology
- Inhibition of renin–angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine
- (2010) Y Nakai et al. BRITISH JOURNAL OF CANCER
- Phase-II trial of combination treatment of interferon-α, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma
- (2010) Manabu Tatokoro et al. CANCER SCIENCE
- Angiotensin blockade in diabetic patients decreases insulin resistance-associated low-grade inflammation
- (2010) Maria G. Pavlatou et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin-converting enzyme is required for normal myelopoiesis
- (2010) Chentao Lin et al. FASEB JOURNAL
- Evaluation of metabolic factors on the prognosis of patients undergoing resection of hepatocellular carcinoma
- (2010) Masaki Kaibori et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
- (2010) Puneeta Tandon et al. JOURNAL OF HEPATOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- Cis-dichlorodiammineplatinum Upregulates Angiotensin II Type 1 Receptors through Reactive Oxygen Species Generation and Enhances VEGF Production in Bladder Cancer
- (2010) N. Tanaka et al. MOLECULAR CANCER THERAPEUTICS
- Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy
- (2009) Stefan Wilop et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Angiotensin II Regulates the Expression of Monocyte Chemoattractant Protein-1 in Pancreatic Cancer Cells
- (2009) Navdeep Chehl et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma
- (2009) Hitoshi Yoshiji et al. JOURNAL OF HEPATOLOGY
- Oral Direct Renin Inhibition: Premise, Promise, and Potential Limitations of a New Antihypertensive Drug
- (2008) Moiz M. Shafiq et al. AMERICAN JOURNAL OF MEDICINE
- Expression of AT1 and AT2 angiotensin receptors in astrocytomas is associated with poor prognosis
- (2008) O Arrieta et al. BRITISH JOURNAL OF CANCER
- The renin-angiotensin system and malignancy
- (2008) E. I. Ager et al. CARCINOGENESIS
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- Expression of Angiotensin-converting Enzyme Changes Major Histocompatibility Complex Class I Peptide Presentation by Modifying C Termini of Peptide Precursors
- (2008) Xiao Z. Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines
- (2008) Takaya Matsuzuka et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Angiotensin II Induces Oxidative Stress in Prostate Cancer
- (2008) H. Uemura et al. MOLECULAR CANCER RESEARCH
- Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer
- (2008) Gunnar Ronquist et al. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started